Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival

Author： Akuta Norio   Suzuki Fumitaka   Suzuki Yoshiyuki   Sezaki Hitomi   Hosaka Tetsuya   Someya Takashi   Kobayashi Masahiro   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kobayashi Mariko   Kumada Hiromitsu  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.40, Iss.6, 2005-06, pp. : 688-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study

By Osaki Yukio  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 444-451

Springer Publishing Company

Access to resources Recommend Favorite

Fas Antigen Expression on Hepatocytes Predicts the Short- and Long-term Response to Interferon Therapy in Patients with Chronic Hepatitis C

By Abe S.   Kotoh K.   Arao S.   Tabaru A.   Otsuki M.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 3, 2001-03 ,pp. : 326-331

Informa Healthcare

Access to resources Recommend Favorite

Effect of interferon therapy on RNA of GB virus C in the patients with chronic hepatitis who were co-infected with hepatitis C virus

By Yasuda K.   Iino S.  

International Hepatology Communications, Vol. 6, Iss. 6, 1997-03 ,pp. : 306-315

Elsevier

Access to resources Recommend Favorite

Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy

By  

Liver Cancer, Vol. 3, Iss. 1, 2014-03 ,pp. : 41-52

Karger

Access to resources Recommend Favorite

Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B

By Papadopoulos Vasileios   Protopapas Andreas   Tsianos Epameinondas   Mimidis Konstantinos  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 8, 2009-08 ,pp. : 1021-1022

Informa Healthcare

Access to resources Recommend Favorite